[1]
Jiang, D.M. , Hamilton, R.J. and Hansen, A.R. 2020. Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time . Canadian Urological Association Journal. 14, 2 (Jan. 2020), 48–9. DOI:https://doi.org/10.5489/cuaj.6407.